Semmax Financial Advisors Inc. Novartis Ag Transaction History

Semmax Financial Advisors Inc.

$355 Million
Q3 2024

A detailed history of Semmax Financial Advisors Inc. transactions in Novartis Ag stock. As of the latest transaction made, Semmax Financial Advisors Inc. holds 11,084 shares of NVS stock, worth $1.09 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares

11,084

Previous 11,238 1.37%

Holding current value

$1.09 Million

Previous $1.2 Million 6.52%

% of portfolio

0.36%

Previous 0.37%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$106.13 - $120.89 $16,344 - $18,617	-154 Reduced 1.37%	11,084 $1.27 Million
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $39,990 - $46,383	432 Added 4.0%	11,238 $1.2 Million
Q1 2024 May 16, 2024	BUY	$95.27 - $108.47 $148,049 - $168,562	1,554 Added 16.8%	10,806 $1.05 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $48,257 - $53,105	523 Added 5.99%	9,252 $934,000
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $92,551 - $102,712	977 Added 12.6%	8,729 $889,000
Q4 2022 Feb 09, 2023	SELL	$75.55 - $92.52 $32,637 - $39,968	-432 Reduced 5.28%	7,752 $716,000
Q3 2022 Nov 15, 2022	SELL	$74.61 - $87.26 $40,513 - $47,382	-543 Reduced 6.22%	8,184 $670,000
Q2 2022 Aug 12, 2022	SELL	$80.52 - $93.75 $52,015 - $60,562	-646 Reduced 6.89%	8,727 $763,000
Q1 2022 May 11, 2022	SELL	$80.11 - $90.62 $118,082 - $133,573	-1,474 Reduced 13.59%	9,373 $823,000
Q4 2021 Mar 01, 2022	SELL	$79.7 - $88.13 $237,027 - $262,098	-2,974 Reduced 21.52%	10,847 $949,000
Q3 2021 Nov 10, 2021	SELL	$81.78 - $95.14 $72,048 - $83,818	-881 Reduced 5.99%	13,821 $1.13 Million
Q2 2021 Aug 11, 2021	SELL	$85.24 - $94.15 $90,098 - $99,516	-1,057 Reduced 6.71%	14,702 $1.34 Million
Q1 2021 May 04, 2021	BUY	$83.5 - $98.47 $118,737 - $140,024	1,422 Added 9.92%	15,759 $1.35 Million
Q4 2020 Feb 05, 2021	BUY	$78.07 - $94.43 $188,773 - $228,331	2,418 Added 20.29%	14,337 $1.35 Million
Q3 2020 Oct 29, 2020	BUY	$82.14 - $91.0 $67,929 - $75,257	827 Added 7.46%	11,919 $1.04 Million
Q2 2020 Jul 17, 2020	BUY	$80.93 - $91.1 $154,171 - $173,545	1,905 Added 20.74%	11,092 $969,000
Q1 2020 May 05, 2020	BUY	$70.67 - $99.01 $210,879 - $295,445	2,984 Added 48.11%	9,187 $757,000
Q4 2019 Feb 03, 2020	BUY	$84.35 - $95.37 $41,668 - $47,112	494 Added 8.65%	6,203 $587,000
Q3 2019 Nov 07, 2019	BUY	$85.54 - $94.26 $74,590 - $82,194	872 Added 18.03%	5,709 $496,000
Q2 2019 Aug 07, 2019	BUY	$75.4 - $92.8 $171,459 - $211,027	2,274 Added 88.72%	4,837 $442,000
Q1 2019 May 07, 2019	BUY	$75.32 - $86.15 $79,537 - $90,974	1,056 Added 70.07%	2,563 $246,000
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $111,005 - $123,604	1,507 New	1,507 $129,000

Others Institutions Holding NVS

# of Institutions

1,437

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $212B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Semmax Financial Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Semmax Financial Advisors Inc. with notifications on news.

Account

Semmax Financial Advisors Inc. Novartis Ag Transaction History